机译:Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?
Department of Clinical Pharmacology,University of Helsinki;
Division of Pharmaceutical Biosciences, Faculty of Pharmacy,University of Helsinki;
Genetics Laboratory, HUS Diagnostic Center,Helsinki University HospitalSouth Karelia Central Hospital;
drug–drug‐interaction; myotoxicity; rhabdomyolysis; rosuvastatin; ticagrelor;